Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008.
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F14%3A%230000745" target="_blank" >RIV/00064190:_____/14:#0000745 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61383082:_____/14:#0000274 RIV/61383082:_____/14:#0000284 RIV/00216224:14110/14:00075537 RIV/00216208:11110/14:10283047 a 6 dalších
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.canep.2013.11.002" target="_blank" >http://dx.doi.org/10.1016/j.canep.2013.11.002</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.canep.2013.11.002" target="_blank" >10.1016/j.canep.2013.11.002</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008.
Popis výsledku v původním jazyce
BACKGROUND: The objective of this study was to assess trends in overall and in stage-specific 5-year relative survival rates of the Czech cancer patients between periods 2000-2004 and 2005-2008. METHODS: All Czech cancer patients diagnosed between 1995 and 2008 were included in the analysis. Period analysis was employed to calculate 5-year relative survival for 21 cancers. RESULTS: Significant improvements in crude 5-year relative survival for 14 of 21 assessed types of cancer, including the most frequent diagnoses, such as, colorectal, prostate, breast, lung, kidney, pancreatic, and bladder cancer and melanoma, were identified. Moreover, in case of colorectal, lung, and prostate cancer, improvement in stage-specific 5-year relative survival was confirmed as statistically significant for all clinical stages. No diagnosis showed significant decrease in the 5-year relative survival. However, the 5-year relative survival remained poor in patients with metastatic cancers at diagnosis, part
Název v anglickém jazyce
Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008.
Popis výsledku anglicky
BACKGROUND: The objective of this study was to assess trends in overall and in stage-specific 5-year relative survival rates of the Czech cancer patients between periods 2000-2004 and 2005-2008. METHODS: All Czech cancer patients diagnosed between 1995 and 2008 were included in the analysis. Period analysis was employed to calculate 5-year relative survival for 21 cancers. RESULTS: Significant improvements in crude 5-year relative survival for 14 of 21 assessed types of cancer, including the most frequent diagnoses, such as, colorectal, prostate, breast, lung, kidney, pancreatic, and bladder cancer and melanoma, were identified. Moreover, in case of colorectal, lung, and prostate cancer, improvement in stage-specific 5-year relative survival was confirmed as statistically significant for all clinical stages. No diagnosis showed significant decrease in the 5-year relative survival. However, the 5-year relative survival remained poor in patients with metastatic cancers at diagnosis, part
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Cancer epidemiology
ISSN
1877-7821
e-ISSN
—
Svazek periodika
38
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
6
Strana od-do
28-34
Kód UT WoS článku
—
EID výsledku v databázi Scopus
—